Literature DB >> 18707679

Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.

Alexa J Stern1, Antonina A Savostyanova, Aaron Goldman, Alan S Barnett, Jan Willem C van der Veen, Joseph H Callicott, Venkata S Mattay, Daniel R Weinberger, Stefano Marenco.   

Abstract

BACKGROUND: This study was conducted to corroborate prior evidence of an effect of the brain-derived neurotrophic factor (BDNF) valine (val) to methionine (met) amino acid substitution at codon 66 (val66met) polymorphism on measures of N-acetyl-aspartate (NAA) containing compounds in healthy subjects.
METHODS: The NAA to creatine (Cre) ratio (NAA/Cre), NAA to choline (Cho) ratio (NAA/Cho), and Cho to Cre ratio (Cho/Cre) were measured in the left and right hippocampi, left and right dorsolateral prefrontal cortices, occipital lobe, anterior cingulate, and white matter of the centrum semiovale of 69 carefully screened healthy volunteers utilizing proton magnetic resonance spectroscopic imaging (MRSI) at 3 Tesla (T).
RESULTS: Val/met subjects exhibited significantly reduced levels of left hippocampal NAA/Cre and NAA/Cho compared with val/val subjects. This effect was independent of age, IQ, number of voxels, hippocampal volume, or gray matter content in the voxels of interest. Analysis of other brain regions showed no effect of BDNF genotype on NAA measures.
CONCLUSIONS: We confirmed the association between the met-BDNF variant and reduced levels of hippocampal NAA found with a similar technique at 1.5T. The consonance of our results with prior findings adds to the evidence that the BDNF val/met genotype affects hippocampal biology with implications for a variety of neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707679      PMCID: PMC2586327          DOI: 10.1016/j.biopsych.2008.07.009

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  69 in total

1.  Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.

Authors:  Josefina Castro-Fornieles; Nuria Bargalló; Luisa Lázaro; Susana Andrés; Carles Falcon; Maria Teresa Plana; Carme Junqué
Journal:  J Psychiatr Res       Date:  2006-11-16       Impact factor: 4.791

2.  Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study.

Authors:  Aaron L Goldman; Lukas Pezawas; Venkata S Mattay; Bruce Fischl; Beth A Verchinski; Brad Zoltick; Daniel R Weinberger; Andreas Meyer-Lindenberg
Journal:  Biol Psychiatry       Date:  2007-08-28       Impact factor: 13.382

3.  Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence.

Authors:  Huiping Zhang; Fatih Ozbay; Jaakko Lappalainen; Henry R Kranzler; Christopher H van Dyck; Dennis S Charney; Lawrence H Price; Steven Southwick; Bao-Zhu Yang; Ann Rasmussen; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

4.  Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking.

Authors:  Undine E Lang; Thomas Sander; Falk W Lohoff; Rainer Hellweg; Malek Bajbouj; Georg Winterer; Jürgen Gallinat
Journal:  Psychopharmacology (Berl)       Date:  2006-12-21       Impact factor: 4.530

5.  Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

Authors:  Thomas Frodl; Cornelius Schüle; Gisela Schmitt; Christine Born; Thomas Baghai; Peter Zill; Ronald Bottlender; Rainer Rupprecht; Brigitta Bondy; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Journal:  Arch Gen Psychiatry       Date:  2007-04

6.  BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects.

Authors:  Joshua A Bueller; Macksood Aftab; Srijan Sen; Diana Gomez-Hassan; Margit Burmeister; Jon-Kar Zubieta
Journal:  Biol Psychiatry       Date:  2006-01-25       Impact factor: 13.382

Review 7.  The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.

Authors:  Heath D Schmidt; Ronald S Duman
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

8.  Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain.

Authors:  Louis N Manganas; Xueying Zhang; Yao Li; Raphael D Hazel; S David Smith; Mark E Wagshul; Fritz Henn; Helene Benveniste; Petar M Djuric; Grigori Enikolopov; Mirjana Maletic-Savatic
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

9.  Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.

Authors:  Tsutomu Takahashi; Michio Suzuki; Masahiko Tsunoda; Yukiko Kawamura; Nagahide Takahashi; Hiroshi Tsuneki; Yasuhiro Kawasaki; Shi-Yu Zhou; Soushi Kobayashi; Toshiyasu Sasaoka; Hikaru Seto; Masayoshi Kurachi; Norio Ozaki
Journal:  Neurosci Lett       Date:  2008-02-09       Impact factor: 3.046

Review 10.  Role of the brain-derived neurotrophic factor at glutamatergic synapses.

Authors:  A L Carvalho; M V Caldeira; S D Santos; C B Duarte
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

View more
  16 in total

1.  Chronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats.

Authors:  Patricia J Allen; Joseph F DeBold; Maribel Rios; Robin B Kanarek
Journal:  Pharmacol Biochem Behav       Date:  2015-01-03       Impact factor: 3.533

2.  BDNF Val66Met polymorphism and brain volumes in multiple sclerosis.

Authors:  D Dinacci; A Tessitore; A Russo; M L De Bonis; L Lavorgna; O Picconi; R Sacco; S Bonavita; A Gallo; G Servillo; L Marcuccio; M Comerci; P Galletti; B Alfano; G Tedeschi
Journal:  Neurol Sci       Date:  2010-10-16       Impact factor: 3.307

3.  Rare copy number deletions predict individual variation in human brain metabolite concentrations in individuals with alcohol use disorders.

Authors:  Ronald A Yeo; Steven W Gangestad; Charles Gasparovic; Jingyu Liu; Vince D Calhoun; Robert J Thoma; Andrew R Mayer; Ravi Kalyanam; Kent E Hutchison
Journal:  Biol Psychiatry       Date:  2011-09-15       Impact factor: 13.382

Review 4.  Psychologically Traumatic Oxidative Stress; A Comprehensive Review of Redox Mechanisms and Related Inflammatory Implications.

Authors:  Evangelos Karanikas
Journal:  Psychopharmacol Bull       Date:  2021-11-03

5.  BDNF Val66Met polymorphism and protein levels in amniotic fluid.

Authors:  Annamaria Cattaneo; Luisella Bocchio-Chiavetto; Roberta Zanardini; Eleonora Marchina; Daniela Bellotti; Elena Milanesi; Stefania Moraschi; Francesca Calabrese; Sergio Barlati; Marco Andrea Riva; Massimo Gennarelli
Journal:  BMC Neurosci       Date:  2010-02-08       Impact factor: 3.288

6.  Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

Authors:  Sanjay J Mathew; James W Murrough; Marije aan het Rot; Katherine A Collins; David L Reich; Dennis S Charney
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-17       Impact factor: 5.176

Review 7.  Imaging genetics of structural brain connectivity and neural integrity markers.

Authors:  Stefano Marenco; Eugenia Radulescu
Journal:  Neuroimage       Date:  2009-11-22       Impact factor: 6.556

8.  Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.

Authors:  Ripu D Jindal; Anil K Pillai; Sahebrao P Mahadik; Kevin Eklund; Debra M Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2010-01-21       Impact factor: 4.939

Review 9.  Modulating neural plasticity with non-invasive brain stimulation in schizophrenia.

Authors:  Alkomiet Hasan; Thomas Wobrock; Tarek Rajji; Berend Malchow; Zafiris J Daskalakis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-24       Impact factor: 5.270

Review 10.  Brain proton magnetic resonance spectroscopy of alcohol use disorders.

Authors:  Dieter J Meyerhoff
Journal:  Handb Clin Neurol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.